[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=cfc668664cc686bab5a63f1e5d461302c64f21800c57d993690bc3a085cf2a48",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742577660,
      "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "id": 133417820,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=cfc668664cc686bab5a63f1e5d461302c64f21800c57d993690bc3a085cf2a48"
    }
  },
  {
    "ts": null,
    "headline": "Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?",
    "summary": "Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=971edf910a549556882acf2737afb14a6e13ad47af7dcf9d4c2c2f7350394b88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742571029,
      "headline": "Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?",
      "id": 133325698,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=971edf910a549556882acf2737afb14a6e13ad47af7dcf9d4c2c2f7350394b88"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs Downgrades Charles River Laboratories International (CRL)",
    "summary": "Goldman Sachs Downgrades Charles River Laboratories International (CRL)",
    "url": "https://finnhub.io/api/news?id=ef18b7f306fea797e1509e1a52215ff8f1c08828fb27a9294cf5f47b7a0323d3",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742558690,
      "headline": "Goldman Sachs Downgrades Charles River Laboratories International (CRL)",
      "id": 133297883,
      "image": "",
      "related": "CRL",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=ef18b7f306fea797e1509e1a52215ff8f1c08828fb27a9294cf5f47b7a0323d3"
    }
  },
  {
    "ts": null,
    "headline": "Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers",
    "summary": "Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers.",
    "url": "https://finnhub.io/api/news?id=c3fad58043d732c5f821dd218f0dc10f0fd0af222303bd88446d8af92f99a13d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742547790,
      "headline": "Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers",
      "id": 133327606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers.",
      "url": "https://finnhub.io/api/news?id=c3fad58043d732c5f821dd218f0dc10f0fd0af222303bd88446d8af92f99a13d"
    }
  }
]